Literature DB >> 10595598

Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium.

B Wagner1, S Begic-Karup, W Raber, B Schneider, W Waldhäusl, H Vierhapper.   

Abstract

Primary Hyperparathyroidism (PHP) often goes unrecognised. Evidence of the influence of thyroid diseases on parathyroid activity exists. In order to determine the prevalence of primary hyperparathyroidism (PHP) in patients with thyroid diseases, a series of patients referred to an outpatient department for patients with thyroid diseases were examined for additional PHP. In addition to screening for thyroid diseases, serum calcium concentration (S-Ca) was measured in a series of persons who came to our outpatients' service for patients with thyroid diseases during the period 1992 to 1998. 13387 persons, median age 48 y, m = 2367, f = 11020, among them 9017 patients with thyroid diseases and 4370 persons without thyroid dysfunction, were studied. In patients with S-Ca outside the normal range, further diagnostic tests relating to PHP were performed. 106/13387 persons showed S-Ca > or = 2.6 mmol/L, in 31 cases due to PHP. In comparison to persons without thyroid diseases, the occurrence of PHP was significantly higher in patients with thyroid diseases (4/4370 = 0.09% vs. 26/9017 = 0.29%). Furthermore, 2 patients with normal S-Ca were diagnosed as having PHP in addition to another endocrine disease (acromegaly, multiple endocrine neoplasia type IIa, resp.). 31 of the 54 persons with S-Ca > 2.6mmol/L and who showed no other reasons for hypercalcaemia were found to be in a hyperthyroid state. The prevalence of PHP was significantly higher in patients with euthyroid goitre (p < 0.05) and in patients with thyroid carcinoma (p = 0.01) as compared to other persons with thyroid diseases. The groups of patients did not differ with regard to age. However, patients without thyroid diseases were significantly younger (median age 38y). Above the age of 50, the prevalence of PHP became higher in patients with euthyroid goitre or thyroid carcinoma than in those with a healthy thyroid gland. In contrast, in persons of under 50 y, there was no difference between these groups. The percentage of males with PHP was higher than in the total population studied (30% vs. 21.5%). In conclusion, a high occurence of PHP could be demonstrated in patients with thyroid diseases (0.29%) as compared to persons without thyroid dysfunction (0.09%), the highest prevalence being in patients with thyroid carcinoma. A clinically not relevant influence of thyroid function on S-Ca was seen in some patients with hyperthyroidism. Determination of S-Ca is recommended for each patient referred to a thyroid outpatients' department because of the high number of PHP cases in this context.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595598     DOI: 10.1055/s-0029-1212138

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

1.  The coexistence of primary hyperparathyroidism and thyroid nodules: should the preoperative work-up of the parathyroid and the thyroid diseases be specifically adjusted?

Authors:  G Scerrino; M Attard; C Lo Piccolo; A Attard; G I Melfa; C Raspanti; M Zarcone; S Bonventre; S Mazzola; G Gulotta
Journal:  G Chir       Date:  2016 May-Jun

2.  Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Authors:  Helene Siilin; Ewa Lundgren; Hans Mallmin; Dan Mellström; Claes Ohlsson; Magnus Karlsson; Eric Orwoll; Osten Ljunggren
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

3.  Incidence of concomitant hyperparathyroidism in patients with thyroid disease requiring surgery.

Authors:  Sara E Murray; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2012-03-30       Impact factor: 2.192

4.  Concomitant thyroid disease and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy.

Authors:  Marie-Christine Wright; Kelly Jensen; Hossam Mohamed; Carolyn Drake; Khuzema Mohsin; Dominique Monlezun; Nuha Alsaleh; Emad Kandil
Journal:  Gland Surg       Date:  2017-08

5.  Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases.

Authors:  Milan D Jovanovic; Vladan R Zivaljevic; Aleksandar D Diklic; Branislav R Rovcanin; Goran V Zoric; Ivan R Paunovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-12       Impact factor: 2.503

Review 6.  Preoperative localization and minimally invasive management of primary hyperparathyroidism concomitant with thyroid disease.

Authors:  Yi-xiong Zheng; Shao-ming Xu; Ping Wang; Li Chen
Journal:  J Zhejiang Univ Sci B       Date:  2007-09       Impact factor: 3.066

7.  Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?

Authors:  QingAn Yu; KunPeng Liu; DaKun Ma; ChangMing Xie; YaoHua Wu; WenJie Dai; HongChi Jiang
Journal:  Biomed Res Int       Date:  2019-07-01       Impact factor: 3.411

8.  Case report: coexistence of primary hyperparathyroidism with giant toxic nodular goiter.

Authors:  Wei Zhang; Fangyi Liu; Kang Chen; Yajing Wang; Jingtao Dou; Yiming Mu; Zhaohui Lyu; Li Zang
Journal:  BMC Endocr Disord       Date:  2022-08-09       Impact factor: 3.263

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.